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Taking risks is a natural human response, but, in some, risk taking is compulsive and may be detrimental. The subthalamic
nucleus (STN) is thought to play a large role in our ability to inhibit responses. Diﬀerences between individuals’ ability to inhibit
inappropriate responses may underlie both the normal variation in trait impulsivity in the healthy population, as well as the
pathological compulsions experienced by those with impulse control disorders (ICDs). Thus, we review the role of the STN in
response inhibition, with a particular focus on studies employing imaging methodology. We also review the latest evidence that
disruption of the function of the STN by deep brain stimulation in patients with Parkinson’s disease can increase impulsivity.
1. Introduction
Some of us are more impulsive than others, more likely to
take risks and suﬀer the consequences or reap the rewards.
Taking risks is a natural human response; we would not be
flying through the skies and sailing across oceans without it.
However, in some, risk taking is compulsive and damaging.
Risk taking that is detrimental may take the form of, for
example, pathological gambling, where suﬀerers are unable
to withhold from placing bets even after losses have become
unmanageable. Other examples include hyper-sexuality,
compulsive eating, and compulsive shopping, all of which
can be described as impulse control disorders (ICDs). ICDs
have been likened phenomenologically, epidemiologically,
and neurologically with substance addiction, and may there-
fore be thought of as behavioral addictions [1].
In individuals with substance or behavioral addictions,
impulsiveness is a common personality trait and may be
associated with a vulnerability for addiction [2]. This vul-
nerability will likely have roots in individuals’ socioeconomic
background, and be heavily influenced by behaviors preva-
lent within ones family and peer group. By cause or con-
sequence, vulnerability to addiction is also associated with
particular patterns of brain chemistry, most notably in the
dopaminergic systems of the basal ganglia [3]. However,
these chemical diﬀerences may not be pathological, but only
normal deviation. For example, in individuals without addic-
tion, the same chemical diﬀerences are associated with the
impulsive personality trait [4]. Thus, when such chemistry
is combined with a lifestyle in which addictive stimuli are
present and often available, addiction is more likely to ensue.
It may not be possible to “treat” vulnerability for addic-
tion if it is based in the normal variation of brain trans-
mitter systems. Instead, how those vulnerabilities aﬀect how
a person is able to control ones responses may be targeted.
Response inhibition, and deficits thereof, is a subject of in-
creased debate in the neuroscientific community. In particu-
lar, how the frontal cortex and basal ganglia, most notably the
subthalamic nucleus (STN), act to allow the fast and eﬀective
inhibition of inappropriate responses is an area of research
currently revealing some interesting findings.
The STN is one node within multiple, segregated cortico-
basal ganglia-thalamo-cortical circuits subserving motor,
cognitive, and aﬀective functions. Dorsal and lateral regions
of the STN connect with sensorimotor areas of the basal gan-
glia and thalamus, premotor, and motor cortical areas. On
the other hand, ventro-medial STN regions communicate
with higher-order cortical regions subserving response inhi-
bition, such as the anterior cingulate cortex (ACC) and
inferior frontal gyrus (IFG) [5–7].
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In this paper, we provide an overview of the current
knowledge of how the STN is involved in response inhibition,
and therefore how disruption to its function, for example,
during deep brain stimulation in Parkinson’s patients, might
contribute to pathologically impulsive behaviors.
2. Imaging of the STN during Impulsivity Tasks
Impulsivity in the motor domain can be measured via the
stop-signal paradigm [8] and the go/no-go paradigm, in
which a “stop” response is pitted against a “go” response. In
a typical experiment, choice reaction times to an imperative
go-stimulus are measured and are followed on a proportion
of trials, after a variable delay (or no delay in the go/no-
go tasks), by a stop-stimulus instructing participants to
withhold their response. Individuals with behavioral and
chemical addictions have been found to perform poorly on
tasks such as these [9–11]. Thus, as mentioned above, impul-
sive behavior may be rooted in impaired response inhibition.
In healthy controls response inhibition, as measured in
stop-signal and go/no-go tasks, is found to be dependent
on activity in the right inferior frontal cortex (IFC) [12–
14], and, more recently, the subthalamic nucleus [12, 15,
16]. It has been proposed that, during stopping, the right
IFC sends a signal via the “hyperdirect” pathway [17] to
the right STN. The STN then expedites the inhibition of
activity in thalamocortical loops related to the action to be
inhibited [12]. In the later paper, the authors found support
for this hypothesis in that there was a blood oxygen level-
dependent (BOLD) response in the STN to stop-signals.
Further, participants with faster reaction times to the stop-
signals showed larger responses than those with shorter
reaction times in both the IFC and the STN, and there
was a significant correlation between stop-signal reaction
times and BOLD responses in these areas across subjects.
Importantly, these authors confirmed that activity during the
stop-signals was located in the STN using high-resolution
structural and functional imaging in a second experiment
within the same paper [12].
Alternatively, Li et al. [16], also measuring BOLD re-
sponses using fMRI during a stop-signal task in healthy
participants, separated stop-trials in which inhibition was
successful from those in which the participant was unable to
withhold from performing the go-response. It was found that
STN activity is the greatest during unsuccessful compared
with successful inhibition. It was also greatest in those indi-
viduals who took longer to respond, or rather, not respond,
to a stop-signal. These findings suggest that the role of the
STN in response inhibition may be to process attentional
aspects of the stop-signal and/or monitor performance,
and not to act as a pathway for faster inhibition of the
go-response. Supporting an attentional role, lesions of the
STN produce attentional deficits in rats [18]. That said,
activity in the STN, recorded in PD patients after deep brain
stimulation surgery, during stopping in a go/no-task [19],
has been shown to increase within frequency bands known
to be associated with a lack of movement in the negative
symptoms of PD [20–23].
Clearly, whatever the STNs’ role in response inhibition,
it must work in tandem with cortical and other brain areas
in order that the conditions of stopping can be incorporated
into the stop response. For example, Aron et al. [15] used
diﬀusion-weighted imaging (DWI) tractography to show
that the IFC and the STN region are connected. They were
also able to report that both the inferior frontal cortex (IFC)
and the STN region are connected with the presupplemen-
tary motor area (preSMA). The authors then found, using
functional magnetic resonance imaging (fMRI) during a
conditional stop-signal paradigm to study the neural control
of slowing of go-responses in the presence of conflict, that
the preSMA, IFC, and STN region were activated more
when conflict-induced slowing was the greatest. Further, as
discussed in more detail below, the anterior cingulate and
its communication with the STN has been implicated in
processes related to response inhibition.
3. Imaging and Behavioral Studies
on DBS of the STN duringMeasures of
Response Inhibition
Deep brain stimulation of the STN improves the motor
symptoms of Parkinson’s disease. It has also allowed us to,
theoretically, interrupt function of the STN for experimental
means. In the next section, we discus how DBS of the STN
might increase impulsiveness in PD patients; here, we discuss
how this impulsiveness might be brought about via inter-
rupted response inhibition.
A prominent paper on the eﬀects of STN DBS on impul-
sivity compared decision making under conflict after DBS
and after dopamine replacement therapy in PD patients [24].
It was found that each of these interventions had their own
eﬀect on impulsiveness during the task. While medication
was shown to impair learning from negative outcomes, DBS
was shown to impair patients’ ability to slow down when
faced with conflict, an ability that serves to allow us time to
settle on the decision most likely to yield positive outcomes.
Thus, both STN DBS and medication may incur impulsive
behavior, but do so via diﬀerent routes.
It must be noted, however, that measuring response inhi-
bition while patients receive DBS has yielded conflicting
results. Response inhibition is shown to improve, remain
unaﬀected, or worsen during DBS [25–30]. Such results may
be due to a marginal role played by the STN in response
inhibition. However, Ray et al. [31], Wylie et al. [32], and
Hershey et al. [33] provide possible explanations for these
discrepancies. Ray et al. describe deficits in inhibitory control
only when improvements on the task due to improved motor
control more generally are controlled for. Wylie et al. describe
dissociabletemporal eﬀects of STN DBS in that stimulation
increased impulsive responding, but also improved the pro-
ficiency with which inhibitory control was engaged. Finally,
Hershey et al. discovered diﬀerences in the eﬀect of STNDBS
on inhibitory control depending on whether the ventral or
dorsal STN is stimulated.
That said, imaging the brain during response inhibi-
tion tasks has revealed interesting results. For example,
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Cambell et al. [29] used PET and [(15)O]-water to measure
STNDBS-induced STNDBS-induced variability in cognitive
performance, focusing on working memory and response
inhibition. They found that STN DBS-induced blood flow
changes in the dorsolateral prefrontal cortex, that correlated
with a change in working memory performance. On the
other hand, STN DBS caused blood flow changes in the
anterior cingulate cortex, that correlated with a change in
response inhibition. This suggests that stimulation of the
STN may induce changes in the cortical (ACC) control of
response inhibition, and the more it does so in individual
patients, the greater the impairment in response inhibitions.
A later PET and [(15)O]-water measured blood flow
during a Go/NoGo and a control (Go) task to study response
inhibition deficits associated with STN-DBS [30]. They
found that STN DBS improved motor scores on the Unified
Parkinson Disease Rating Scale, but impaired response
inhibition, measured as a greater number of errors during
NoGo trials. The PET results revealed that changes on the
task were accompanied by reduced activation in the left
PMC, pre-SMA, dorsal ACC, and IFC, areas thought to
subserve retroactive response inhibition in which a stimulus
to stop must be processed and acted upon in order that
inhibition is successful. The authors also found reduced
activation in the precuneus and left inferior parietal cortex,
which they argue play an important role, via interaction with
the medial prefrontal cortex, in proactive (preparing to stop)
inhibitory processes.
Given the data above, it seems that the STN plays a
large role in response inhibition via its connections within
the basal ganglia as well as areas of cortex involved in the
cognitive aspects of controlling actions, such as the ACC,
IFC, the medial prefrontal cortex, and dorsolateral prefrontal
cortex. Thus, it is interesting to note that altered activity
in some of these areas is found to be associated with the
development ICDs in both the general population [34] and
in PD patients who develop an ICD subsequent to dopamine
replacement medications [35].
4. Does DBS of the STN Induce Impulsive
Control Disorders?
Given the research discussed above, the question of whether
DBS of the STN can alter patients’ tendency to be impul-
sive one way or the other must be asked. Up to now,
several conflicting reports have stressed a direct correlation
between STN-DBS and impulse control disorders (ICDs). In
some reports, patients with preoperative ICDs significantly
improved after surgery [36–38]. However, in all cases, the
phenomena was accompanied by a significant reduction of
dopaminergic therapy. It was argued, therefore, that this
improvement may be explained by pharmacological therapy
reduction rather than the introduction of STN DBS [37].
In other reports, however, the development of an ICD was
reported to occur secondary to STN-DBS [38–43]. In these
cases, the disorder appeared a few months after surgery and
was transient, resolving within a year of its development
[42, 43]. Some authors suggest that psychosocial factors, such
as male gender and patient compliance, might influence the
potential for the development of an ICD after STNDBS [38].
A behavior closely related to ICDs is the development
of excessive or inappropriate levodopa use, or drug hording,
described as a symptom of hedonistic homeostatic deregu-
lation by Giovannoni et al. [44]. This condition has been
described postoperatively in one patient treated with STN
DBS [44]; however, most of the time this behavior develops
preoperatively [43, 45].
More recently, a few prospective, but more frequently
retrospective, trials were conducted in order to better under-
stand the incidence and prevalence of ICDs in DBS STN
patients and to confirm a possible direct role of STN surgery
in inducing impulsive behaviors. However, to date, a scarcity
of data precludes our ability to make any firm conclusions
regarding the causal role of STN DBS in the development
of ICDs. That said, a recent cross-sectional study assessed
the degree of trait impulsivity in a group of 16 PD patients
with STN DBS and a group of 37 PD patients without
DBS, matched for levodopa equivalent doses (LEDD). The
evaluation, performed only postoperatively, observed ICDs
in 19% of DBS PD patients (3/16) and in 8% (3/37) of the
non-DBS PD patients. The authors concluded that STN DBS
might induce ICDs in PD. However, such inferences are lim-
ited without a preoperative evaluation [46]. Lim et al. [38],
following a series of 21 patients with ICDs and dopamine
disregulation syndrome (DDS) at some stage after the onset
of PD, found, from 17 patients with preoperative problems,
10 who experienced a worsening or no improvement of their
ICDs after STN DBS, 5 who improved or resolved and 3 who
developed ex novo DDS and ICDs after the surgery. Further,
the authors noted that the behavioral response to STN DBS
might be predicted by the vigilance of the physician, the
motor outcome and patient compliance. Finally, in a recent
study on punding (the appearance of repetitive, complex,
and stereotypical behaviors), using a patient and relative
completed survey of 24 consecutive PD patients with STN
DBS [47], 20.8% (5/24 in a group of PDDBS) were identified
as punders, a higher percentage than the 14% (17/123 in a
group of PD) previously found by Evans in a subgroup of PD
on dopaminergic therapy, or 1,4% (4/291 in a group of PD)
recently identified byMiyasaki in the same group. The higher
ratio might be due to diﬀerences in the population studied.
While the studies above seem to suggest more impulsive
behavior after STN DBS, Houeto et al., in a retrospective
study on 24 patients, using a rating scale of personality
change, found no diﬀerences in impulsivity pre- versus
postoperatively in STN DBS PD patients [43].
As discussed above, many studies have attempted to test
some of the underlying constructs of impulsive disorders,
that is, using tasks that measuring motor and cognitive
impulsivity. The majority of these studies have shown
impairment while STN stimulation is on versus oﬀ [25, 27,
47–50]. However, Pillon et al. [50] found no diﬀerences on
a gambling task in patients with STN DBS turned on versus
oﬀ.
In conclusion, although these studies suggest overall that
impulsive disorders may be related to STN DBS, we would
like to stress the need for larger, prospective, controlled
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trials to better understand the role of DBS in inducing
ICDs. Recently, it has been proposed that impulsive patients
might be at greater risk for postoperative suicide attempts
[51]; however so far, there is no evidence supporting the
presence of preoperative ICDs as a criterion of exclusion for
surgery [51]. Neither do we have much inclination how to
manage impulsive disorders that may appear postoperatively.
In the case of ICDs occuring preoperatively, Voon et al.
[52] have suggested that the relationship between ICDs
and medication should be assessed before proceeding with
surgery. If the problem persists, surgery should only be
an option after an evaluation of the patients’ cognitive
status, their support, the intensity of the disorder and the
patients’ capacity for behavioral control. In the case of post-
operative ICDs, Voon suggests medication reduction should
be tried before considering a decrease in the intensity of the
stimulation. Finally, she suggests that patients may benefit
from the addition of an atypical antipsychotic to their reg-
ular medication, and from a multidisciplinary approach to
managing the problem.
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